Tango Therapeutics Shares Gap Up on Insider Buying Activity

TNGX Stock  USD 2.85  0.25  8.06%   
Slightly above 73% of Tango Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Tango Therapeutics suggests that many traders are alarmed. Tango Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tango Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Tango Therapeutics, Inc. gapped up before the market opened on Wednesday after an insider bought additional shares in the company. The stock had previously closed at 7.20, but opened at 7.83. Tango Therapeutics shares last traded at 7.14, with a volume of 182,394 shares changing hands. Specifically, insider Boxer Capital,

Read at thelincolnianonline.com
news
  

Tango Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tango Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tango Therapeutics Fundamental Analysis

We analyze Tango Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tango Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tango Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Tango Therapeutics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Tango Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tango Therapeutics stock to make a market-neutral strategy. Peer analysis of Tango Therapeutics could also be used in its relative valuation, which is a method of valuing Tango Therapeutics by comparing valuation metrics with similar companies.

Peers

Tango Therapeutics Related Equities

PASGPassage Bio   2.63   
0%
21.0%
BDTXBlack Diamond   0.79   
6.0%
0%
XLOXilio Development   0.96   
7.0%
0%
PLRXPliant Therapeutics   2.46   
19.0%
0%
CGEMCullinan Oncology   2.56   
20.0%
0%
TYRATyra Biosciences   2.94   
23.0%
0%
RVMDRevolution Medicines   3.23   
26.0%
0%
NRIXNurix Therapeutics   3.40   
27.0%
0%
RLAYRelay Therapeutics   4.02   
32.0%
0%
THRDThird Harmonic   4.90   
39.0%
0%
STOKStoke Therapeutics   5.08   
40.0%
0%
RAPTRAPT Therapeutics   5.50   
44.0%
0%
EWTXEdgewise Therapeutics   5.54   
44.0%
0%
MLYSMineralys Therapeutics,   6.02   
48.0%
0%
KYMRKymera Therapeutics   6.33   
50.0%
0%
FHTXFoghorn Therapeutics   6.47   
52.0%
0%
CNTBConnect Biopharma   6.50   
52.0%
0%
RLYBRallybio Corp   6.67   
53.0%
0%
GLUEMonte Rosa   8.46   
68.0%
0%
STTKShattuck Labs   9.77   
78.0%
0%
ARVNArvinas   12.42   
100.0%
0%

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.